Tissue kallikrein is related to the severity of coronary artery disease

Yu-yu Yao1, Cong Fu, Gen-shan Ma

  • 1Department of Cardiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, Jiangsu 210009, China. yaoyuyunj@hotmail.com

Insights

Elevated tissue kallikrein (KLK1) levels predict coronary artery disease (CAD) presence and severity. Higher KLK1 indicates greater CAD extent and risk of major adverse cardiovascular events (MACE) in ACS patients.

Area of Science:

  • Cardiovascular Research
  • Biochemistry
  • Pathophysiology

Background:

  • The tissue kallikrein (KLK1)-kinin system (KKS) plays a role in atheroma development.
  • The correlation between KKS and coronary artery disease (CAD) requires further investigation.

Purpose of the Study:

  • To investigate the association between plasma KLK1 levels and the presence, severity, and outcomes of CAD.
  • To explore the role of KLK1 in the pathophysiology of coronary plaques.

Main Methods:

  • Measured plasma KLK1, VEGF, and hs-CRP in 100 CAD patients and 33 controls.
  • Followed patients for major adverse cardiovascular events (MACE).
  • Assessed KLK1 gene expression and protein localization in coronary endarterectomy specimens.

Main Results:

  • CAD and acute coronary syndrome (ACS) patients exhibited significantly elevated KLK1 plasma levels.
  • Plasma KLK1 strongly correlated with CAD severity and independently predicted CAD presence.
  • KLK1 levels correlated with MACE in ACS patients and were elevated in unstable plaques, co-localizing with macrophages.

Conclusions:

  • Plasma KLK1 levels are a valuable predictor for the presence and extent of CAD.
  • Further extensive studies are needed to validate these findings and their clinical implications.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...